Chemistry:F-14258

From HandWiki

F-14258 is a serotonin 5-HT1B and 5-HT1D receptor antagonist which was under development for the treatment of major depressive disorder (MDD) and obsessive–compulsive disorder (OCD) but was never marketed.[1][2] It is taken orally.[1] The drug was under development by Pierre Fabre.[1][2] It reached the preclinical research stage of development prior to its discontinuation around 2002.[1][2]

See also

References